Skip to content

Clinical trials

Burkitt Lymphoma trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Status: Unknown status Clear all

90 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20022
20032
20042
20052
20072
20082
20092
20101
20111
20121
20143
20153
20164
20176
20187
20197
20205
20217
20228
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status90

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shenzhen BinDeBio Ltd.4
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China3
Jonsson Comprehensive Cancer Center3
The First Affiliated Hospital of Soochow University3
Anhui Provincial Hospital2
Auxilio Mutuo Cancer Center2
Beijing Immunochina Medical Science & Technology Co., Ltd.2
Gilead Sciences2
Hebei Yanda Ludaopei Hospital2
Henan Cancer Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma90
Lymphoma35
Precursor Cell Lymphoblastic Leukemia-Lymphoma33
Lymphoma, Large B-Cell, Diffuse32
Lymphoma, Follicular31
Lymphoma, Non-Hodgkin30
Lymphoma, Large-Cell, Immunoblastic27
Lymphoma, Mantle-Cell26
Leukemia, Lymphocytic, Chronic, B-Cell25
Lymphoma, B-Cell, Marginal Zone23

Trials

Showing 51 to 75 of 90. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.